Clinical trial
Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women
NCT00056082 · University of Kansas Medical Center, Other · Completed
Key facts
| NCT number | NCT00056082 |
|---|---|
| Title | Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women |
| Official title | A Study to Identify Biomarker Modulation by a Cyclooxygenase-2 (COX-2) Inhibitor in Breast Tissue of Premenopausal Women at High Risk for Estrogen Receptor Negative (ERN) Breast Cancer |
| Lead sponsor | University of Kansas Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | celecoxib |
| Enrollment | 110 |
| Start date | Jan 1, 2003 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2013 |
| First posted | Mar 7, 2003 |
| Last update posted | Feb 15, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: